Skip to main content

Gabelli Funds LLC

SEC CIK
0001081407
Latest filing
Aug 12, 2026

JNCE holding history

Jounce Therapeutics, Inc. in every 13F filed by Gabelli Funds LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

JNCE overviewAll 13F holders of JNCEFull Q2 2026 holdings

Shares (Q2 2023)
0
Sold out in Q2 2023
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q1 2023
Holdings of JNCE by Gabelli Funds LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20230$00.0%−526,281−100.0%Sold outHolders
Q1 2023526,281$973.6K<0.1%+526,281NewHolders